Skip to content

Faculty profile

David Grierson

Back to faculty
ResearcherUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response.

    Oncotarget · 2024

  • The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation

    Viruses · 2022

  • Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production.

    PLoS pathogens · 2020

All 3 publications

Latest funding

  • Development of Novel Polar MAO B Inhibitors for the Treatment of Epithelial Barrier Diseases

    CIHR · 2014 · Co-investigator

    $160,000
  • Development of Specific Inhibitors of HIV pre-mRNA Alternative Splicing: A New Anti-HIV/AIDS Strategy

    CIHR · 2014 · Nominated PI

    $160,000
  • CREATE Sustainable Synthesis

    NSERC · 2013 · Co-investigator

    $1,575,000
All 7 grants and awards
Something wrong or missing on this profile? Suggest a correction